Developer docs
API playgroundTry for free, no card

Search company profiles

Credence MedSystems

Full company profile

uuid0000hqe

Namestring
Credence MedSystems
Legal namestring
Credence MedSystems, Inc.
Websiteurl
credencemed.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Credence MedSystems is a private medical device and drug delivery company headquartered in Menlo Park, California, focused on proprietary injectable delivery platforms for pharmaceutical and biotechnology manufacturers. The company has operated since approximately 2011–2014 and has built a portfolio of branded syringe-based systems targeting biologics, ophthalmics, aesthetics, and global health applications. Its customer base is enterprise B2B, comprising pharma and biotech sponsors that integrate Credence's devices into combination products and branded therapeutics. The company is small (11–50 employees) and remains privately held, with cumulative funding of roughly $77.5M+ across multiple rounds and a strategic investor base that includes Novartis, Molex, and the Bill & Melinda Gates Foundation.

The product portfolio centers on the Companion® Safety Syringe System (Staked Needle and Luer variants) with enhancements including Multi-Length Staked Needle, Needle Mask, and Needle Isolation Valve; the Dual Chamber Syringe System for reconstitution and sequential delivery; the Micro-Dose™ Syringe System for ophthalmic applications; the Multi-Site™ Syringe System for aesthetics; and the Credence Connect™ connected health platform, developed in collaboration with Phillips-Medisize as a connected autoinjector. The technology is mechanical and pharmaceutical rather than data-driven, with safety, convenience, and connectivity positioned as the differentiators versus commodity syringe supply. The Dual Chamber system has been supported by a Gates Foundation grant, signaling relevance to global health reconstitution use cases.

Commercially, Credence generates revenue through custom development, licensing, and commercial supply agreements with pharma and biotech customers, leveraging contract manufacturing and fill-finish partners (Phillips-Medisize and SMC Ltd.) for scaled production rather than building in-house sterile capacity. Strategic capital from Novartis (a pharma manufacturer) and Molex (a global connector solutions provider) doubles as both funding and go-to-market validation. The company has moved from a development-stage posture to early commercial supply, with a global biopharma leader agreement for ophthalmic drug delivery announced in January 2026, and a small set of anchor customers such as Azura Ophthalmics. Customer concentration is correspondingly high, and revenue predictability depends on the trajectory of a limited number of combination product programs.

Short descriptiontext

Credence MedSystems is a private drug delivery device company developing proprietary safety syringes, dual chamber, micro-dose, multi-site, and connected health platforms for pharmaceutical and biotechnology manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
injectable drug delivery, safety syringe systems, prefilled syringe devices, dual chamber syringes, connected injection systems
Industry1 code
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Injectable Drug Delivery Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Drug Delivery Device Sales
TypeHardware Sales
Description

Credence MedSystems generates revenue through the sale of proprietary drug delivery devices and systems to pharmaceutical and biotechnology manufacturers. The company offers multiple platform products including the Companion Syringe System, Dual Chamber Syringe System, and Metered Dosing Systems. Revenue is generated from device sales, custom development partnerships, and potentially licensing of technology. Commercial supply agreements with pharmaceutical customers drive recurring revenue relationships.

credencemed.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Companion
Description

Companion Syringe System - featuring Staked Needle and Luer options with integrated safety and usability features

credencemed.com
+5 more records
Core offering1 text field

Credence MedSystems designs, develops, and sells proprietary injectable drug delivery devices to pharmaceutical and biotechnology manufacturers. Its portfolio includes the Companion Safety Syringe System (Staked Needle and Luer variants), Dual Chamber Reconstitution and Sequential Syringe Systems, Metered Dosing Systems (Micro-Dose, Multi-Site, Force-Assist), the Credence Connect connected health injection system, custom product development services, and prefilled pharmaceutical capabilities. The offering is built on the "Innovation Without Change" philosophy, allowing manufacturers to add safety, usability, sustainability, and connected features without disrupting existing syringe platforms or validated processes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 54% reduction in added component weight compared to conventional add-on safety approach
+3 more records
Product overview1 text field

Credence MedSystems offers a comprehensive portfolio of injectable drug delivery devices built on their 'Innovation Without Change®' philosophy, enabling pharmaceutical manufacturers to enhance products without disrupting existing processes. The core product families include: the Companion® Syringe System (available as Staked Needle and Luer variants) providing integrated safety and usability features; the Dual Chamber Syringe System (Reconstitution and Sequential options) for drugs requiring separate storage of constituents; Metered Dosing Products (Micro-Dose™ for ophthalmic applications, Multi-Site™ for cosmetic/therapeutic injections, and Force-Assist™ for high-viscosity formulations); and Connected Health Products (Credence Connect™ Auto-Sensing Injection System and Phillips-Medisize Connected Autoinjector). The portfolio also includes delivery system enhancements (Multi-Length Staked Needle, Needle Mask™, Needle Isolation Valve™), manual and autoinjector accessories, custom product development services, and prefilled pharmaceuticals capabilities. All products are designed to work with industry-standard syringe barrels, plunger stoppers, and needle shields.

Product and service10 records
1Companion Staked Needle Syringe
CategorySafety Syringe System
Description

Flagship safety syringe with pre-attached (staked) needle, featuring automatic passive needle retraction, reuse prevention, and end-of-dose cues. Designed to reduce manufacturing steps and waste, accommodate high viscosity drugs, and improve sustainability versus conventional add-on safety systems. Targeted at pharmaceutical manufacturers developing injectable combination products.

2Companion Luer Syringe
CategorySafety Syringe System
Description

Luer-based variant of the Companion safety syringe system with a Guide-On Needle Cover to support proper user needle attachment. Provides passive needle retraction and end-of-dose cues while letting users attach their preferred needle, targeted at pharmaceutical manufacturers whose combination products use a Luer interface.

3Dual Chamber Reconstitution Syringe
4Dual Chamber Sequential Syringe
5Micro-Dose Syringe System
6Multi-Site Syringe System
7Credence Connect Auto-Sensing Injection System
8Connected Autoinjector (Phillips-Medisize collaboration)
9Custom Product Development
10Prefilled Pharmaceuticals
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Global Biopharmaceutical Leader (unnamed)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-07
Description

Commercial supply agreement announced January 7, 2026 with a global biopharmaceutical leader for ophthalmic drug delivery products. This represents Credence's first major commercial supply agreement for their drug delivery systems in the ophthalmology market segment.

credencemed.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-23
Description

Collaboration announced September 23, 2025 to advance Dual Chamber fill-finish capabilities. The partnership enables Credence's dual chamber syringe device configuration to be used with SMC's contract manufacturing services, allowing an array of CMOs to perform dual chamber fill finish with modest investment and minimal changes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-19
Description

Strategic collaboration announced October 19, 2021 to develop a connected autoinjector compatible with the Credence Companion and Dual Chamber syringe systems. The collaboration leverages Phillips-Medisize's device manufacturing expertise to provide a suite of disposable and reusable autoinjectors that incorporate Credence's integrated safety and usability features.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

West Pharma is a leading provider of primary packaging and drug delivery components for injectable pharmaceuticals, including elastomeric stoppers, syringe plungers, and integrated delivery systems — directly comparable to Credence's prefilled syringe and combination-product offering.

TypeBroad incumbent
Description

BD is one of the largest manufacturers of prefilled syringes, safety syringes, and injectable drug delivery devices globally, serving the same pharmaceutical manufacturer customer base as Credence across a much broader portfolio.

TypeDirect peer
Description

Gerresheimer manufactures primary packaging and drug delivery devices (syringes, vials, autoinjectors) for pharma and biotech — competing directly with Credence's syringe platforms and combination-product capabilities.

TypeDirect peer
Description

Stevanato produces drug containment and delivery solutions including syringes, vials, and integrated devices for injectable therapeutics — overlapping with Credence's prefilled syringe and combination-product focus.

TypeDirect peer
Description

Ypsomed is a specialist developer and manufacturer of injection systems (autoinjectors, pen injectors, safety syringes) for pharmaceutical and biotech customers — directly comparable to Credence's delivery-device portfolio.

TypeDirect peer
Description

SHL Medical designs and manufactures advanced drug delivery systems including autoinjectors and pen injectors for global pharma, directly competing for injectable device programs of the type Credence targets.

TypeDirect peer
Description

Phillips-Medisize is a contract developer and manufacturer of drug delivery devices (autoinjectors, connected injectors) — Credence's announced collaboration partner on connected autoinjectors and a direct peer in combination-product device manufacturing.

TypeDirect peer
Description

Owen Mumford develops and manufactures drug delivery devices including auto-injectors, pen injectors, and safety lancets for pharmaceutical manufacturers — overlapping with Credence's safety and connected device offerings.

TypeBroad incumbent
Description

SCHOTT Pharma manufactures primary packaging and drug delivery solutions (syringes, vials, ampoules, cartridges) for the global pharma industry — a broader incumbent competing with Credence across prefilled syringe platforms.

TypeBroad incumbent
Description

Catalent provides drug delivery and fill-finish services including prefilled syringe manufacturing and combination-product support — overlapping with Credence's prefilled pharmaceutical and combination-product device offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Credence MedSystems

Injectable Drug Delivery Devicescredencemed.com

Credence MedSystems is a private drug delivery device company developing proprietary safety syringes, dual chamber, micro-dose, multi-site, and connected health platforms for pharmaceutical and biotechnology manufacturers.

What Credence MedSystems does

Credence MedSystems is a private medical device and drug delivery company headquartered in Menlo Park, California, focused on proprietary injectable delivery platforms for pharmaceutical and biotechnology manufacturers. The company has operated since approximately 2011–2014 and has built a portfolio of branded syringe-based systems targeting biologics, ophthalmics, aesthetics, and global health applications. Its customer base is enterprise B2B, comprising pharma and biotech sponsors that integrate Credence's devices into combination products and branded therapeutics. The company is small (11–50 employees) and remains privately held, with cumulative funding of roughly $77.5M+ across multiple rounds and a strategic investor base that includes Novartis, Molex, and the Bill & Melinda Gates Foundation.

The product portfolio centers on the Companion® Safety Syringe System (Staked Needle and Luer variants) with enhancements including Multi-Length Staked Needle, Needle Mask, and Needle Isolation Valve; the Dual Chamber Syringe System for reconstitution and sequential delivery; the Micro-Dose™ Syringe System for ophthalmic applications; the Multi-Site™ Syringe System for aesthetics; and the Credence Connect™ connected health platform, developed in collaboration with Phillips-Medisize as a connected autoinjector. The technology is mechanical and pharmaceutical rather than data-driven, with safety, convenience, and connectivity positioned as the differentiators versus commodity syringe supply. The Dual Chamber system has been supported by a Gates Foundation grant, signaling relevance to global health reconstitution use cases.

Commercially, Credence generates revenue through custom development, licensing, and commercial supply agreements with pharma and biotech customers, leveraging contract manufacturing and fill-finish partners (Phillips-Medisize and SMC Ltd.) for scaled production rather than building in-house sterile capacity. Strategic capital from Novartis (a pharma manufacturer) and Molex (a global connector solutions provider) doubles as both funding and go-to-market validation. The company has moved from a development-stage posture to early commercial supply, with a global biopharma leader agreement for ophthalmic drug delivery announced in January 2026, and a small set of anchor customers such as Azura Ophthalmics. Customer concentration is correspondingly high, and revenue predictability depends on the trajectory of a limited number of combination product programs.

Credence MedSystems firmographics

Firmographics
Name
Credence MedSystems
Legal name
Credence MedSystems, Inc.
Website
https://credencemed.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Credence MedSystems is a private drug delivery device company developing proprietary safety syringes, dual chamber, micro-dose, multi-site, and connected health platforms for pharmaceutical and biotechnology manufacturers.
Ownership category
akta.pro rank

Credence MedSystems industry classification

Industry
Product category
Injectable Drug Delivery Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Injectable drug delivery
  • Safety syringe systems
  • Prefilled syringe devices
  • Dual chamber syringes
  • Connected injection systems

Where Credence MedSystems is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Credence MedSystems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Drug Delivery Device Sales: Credence MedSystems generates revenue through the sale of proprietary drug delivery devices and systems to pharmaceutical and biotechnology manufacturers. The company offers multiple platform products including the Companion Syringe System, Dual Chamber Syringe System, and Metered Dosing Systems. Revenue is generated from device sales, custom development partnerships, and potentially licensing of technology. Commercial supply agreements with pharmaceutical customers drive recurring revenue relationships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Credence MedSystems product offering

Product offering

Core offering

Credence MedSystems designs, develops, and sells proprietary injectable drug delivery devices to pharmaceutical and biotechnology manufacturers. Its portfolio includes the Companion Safety Syringe System (Staked Needle and Luer variants), Dual Chamber Reconstitution and Sequential Syringe Systems, Metered Dosing Systems (Micro-Dose, Multi-Site, Force-Assist), the Credence Connect connected health injection system, custom product development services, and prefilled pharmaceutical capabilities. The offering is built on the "Innovation Without Change" philosophy, allowing manufacturers to add safety, usability, sustainability, and connected features without disrupting existing syringe platforms or validated processes.

Product overview

Credence MedSystems offers a comprehensive portfolio of injectable drug delivery devices built on their 'Innovation Without Change®' philosophy, enabling pharmaceutical manufacturers to enhance products without disrupting existing processes. The core product families include: the Companion® Syringe System (available as Staked Needle and Luer variants) providing integrated safety and usability features; the Dual Chamber Syringe System (Reconstitution and Sequential options) for drugs requiring separate storage of constituents; Metered Dosing Products (Micro-Dose™ for ophthalmic applications, Multi-Site™ for cosmetic/therapeutic injections, and Force-Assist™ for high-viscosity formulations); and Connected Health Products (Credence Connect™ Auto-Sensing Injection System and Phillips-Medisize Connected Autoinjector). The portfolio also includes delivery system enhancements (Multi-Length Staked Needle, Needle Mask™, Needle Isolation Valve™), manual and autoinjector accessories, custom product development services, and prefilled pharmaceuticals capabilities. All products are designed to work with industry-standard syringe barrels, plunger stoppers, and needle shields.

Differentiator

Problem solved

Functional benefit

Brands

  • Companion: Companion Syringe System - featuring Staked Needle and Luer options with integrated safety and usability features
  • Credence Connect
  • Micro-Dose
  • Multi-Site
  • Force-Assist
  • Dual Chamber

Products and services

  • Companion Staked Needle Syringe Flagship safety syringe with pre-attached (staked) needle, featuring automatic passive needle retraction, reuse prevention, and end-of-dose cues. Designed to reduce manufacturing steps and waste, accommodate high viscosity drugs, and improve sustainability versus conventional add-on safety systems. Targeted at pharmaceutical manufacturers developing injectable combination products.
  • Companion Luer Syringe Luer-based variant of the Companion safety syringe system with a Guide-On Needle Cover to support proper user needle attachment. Provides passive needle retraction and end-of-dose cues while letting users attach their preferred needle, targeted at pharmaceutical manufacturers whose combination products use a Luer interface.
  • Dual Chamber Reconstitution Syringe
  • Dual Chamber Sequential Syringe
  • Micro-Dose Syringe System
  • Multi-Site Syringe System
  • Credence Connect Auto-Sensing Injection System
  • Connected Autoinjector (Phillips-Medisize collaboration)
  • Custom Product Development
  • Prefilled Pharmaceuticals

Quantifiable outcome

  • 54% reduction in added component weight compared to conventional add-on safety approach
  • +3 more outcomes

Companies that use Credence MedSystems

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Credence MedSystems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Credence MedSystems partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Global Biopharmaceutical Leader (unnamed)coreChannel Partner/ Reseller/ Distributor · 7 January 2026Commercial supply agreement announced January 7, 2026 with a global biopharmaceutical leader for ophthalmic drug delivery products. This represents Credence's first major commercial supply agreement for their drug delivery systems in the ophthalmology market segment.
  • SMC Ltd. Pharma ServicescoreStrategic or Co-development Partner · 23 September 2025Collaboration announced September 23, 2025 to advance Dual Chamber fill-finish capabilities. The partnership enables Credence's dual chamber syringe device configuration to be used with SMC's contract manufacturing services, allowing an array of CMOs to perform dual chamber fill finish with modest investment and minimal changes.
  • Phillips-MedisizecoreStrategic or Co-development Partner · 19 October 2021Strategic collaboration announced October 19, 2021 to develop a connected autoinjector compatible with the Credence Companion and Dual Chamber syringe systems. The collaboration leverages Phillips-Medisize's device manufacturing expertise to provide a suite of disposable and reusable autoinjectors that incorporate Credence's integrated safety and usability features.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Credence MedSystems competitors and assessment

Company assessment

Direct peers

  • West Pharmaceutical Services: West Pharma is a leading provider of primary packaging and drug delivery components for injectable pharmaceuticals, including elastomeric stoppers, syringe plungers, and integrated delivery systems — directly comparable to Credence's prefilled syringe and combination-product offering.
  • Gerresheimer: Gerresheimer manufactures primary packaging and drug delivery devices (syringes, vials, autoinjectors) for pharma and biotech — competing directly with Credence's syringe platforms and combination-product capabilities.
  • Stevanato Group: Stevanato produces drug containment and delivery solutions including syringes, vials, and integrated devices for injectable therapeutics — overlapping with Credence's prefilled syringe and combination-product focus.
  • Ypsomed: Ypsomed is a specialist developer and manufacturer of injection systems (autoinjectors, pen injectors, safety syringes) for pharmaceutical and biotech customers — directly comparable to Credence's delivery-device portfolio.
  • SHL Medical: SHL Medical designs and manufactures advanced drug delivery systems including autoinjectors and pen injectors for global pharma, directly competing for injectable device programs of the type Credence targets.
  • Phillips-Medisize: Phillips-Medisize is a contract developer and manufacturer of drug delivery devices (autoinjectors, connected injectors) — Credence's announced collaboration partner on connected autoinjectors and a direct peer in combination-product device manufacturing.
  • Owen Mumford: Owen Mumford develops and manufactures drug delivery devices including auto-injectors, pen injectors, and safety lancets for pharmaceutical manufacturers — overlapping with Credence's safety and connected device offerings.

Broad incumbents

  • Becton Dickinson (BD): BD is one of the largest manufacturers of prefilled syringes, safety syringes, and injectable drug delivery devices globally, serving the same pharmaceutical manufacturer customer base as Credence across a much broader portfolio.
  • SCHOTT Pharma: SCHOTT Pharma manufactures primary packaging and drug delivery solutions (syringes, vials, ampoules, cartridges) for the global pharma industry — a broader incumbent competing with Credence across prefilled syringe platforms.
  • Catalent: Catalent provides drug delivery and fill-finish services including prefilled syringe manufacturing and combination-product support — overlapping with Credence's prefilled pharmaceutical and combination-product device offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Credence MedSystems social profiles

Digital presence

Credence MedSystems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Credence MedSystems leadership team

Management profile

Number of profiles

Profiles9 records

Credence MedSystems funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Credence MedSystems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Credence MedSystems

What does Credence MedSystems do?

Credence MedSystems designs, develops, and sells proprietary injectable drug delivery devices to pharmaceutical and biotechnology manufacturers. Its portfolio includes the Companion Safety Syringe System (Staked Needle and Luer variants), Dual Chamber Reconstitution and Sequential Syringe Systems, Metered Dosing Systems (Micro-Dose, Multi-Site, Force-Assist), the Credence Connect connected health injection system, custom product development services, and prefilled pharmaceutical capabilities. The offering is built on the "Innovation Without Change" philosophy, allowing manufacturers to add safety, usability, sustainability, and connected features without disrupting existing syringe platforms or validated processes.

Is Credence MedSystems a public or private company?

Credence MedSystems is a private company. It is classified as venture growth investor backed and is currently operating.

When was Credence MedSystems founded?

Credence MedSystems was founded in 2014. It employs 11 to 50 people.

Where is Credence MedSystems based?

Credence MedSystems is headquartered in Menlo Park, United States, in the North America region.

How does Credence MedSystems make money?

One revenue line is on record: drug Delivery Device Sales.

Who are Credence MedSystems's main competitors?

Direct peers on record are West Pharmaceutical Services, Gerresheimer, Stevanato Group, Ypsomed, SHL Medical, Phillips-Medisize and Owen Mumford. Broad incumbents are Becton Dickinson (BD), SCHOTT Pharma and Catalent.

Does Credence MedSystems have an API?

No public API is recorded for Credence MedSystems.

What industry is Credence MedSystems in?

Credence MedSystems's product category is Injectable Drug Delivery Devices. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogCredence MedSystems Announces a Significant Milestone Towards Scaling Manufacturing CapabilitiesCredence MedSystems announced the successful completion of Factory Acceptance Testing for its new Clinical Assembly Line dedicated to producing Companion® injection devices. The equipment, supplied by Mikron Automation, will be transported from Denver to Phillips-Medisize's facility in Letterkenny, Ireland, for ongoing manufacturing operations. This milestone enables Credence to supply GMP clinical products to pharmaceutical customers, including Novartis and Molex Ventures, supporting device verification and drug stability studies.BioSpaceCredence MedSystems Announces Strategic Collaboration With Phillips-MedisizeCredence MedSystems announced a strategic collaboration with Phillips-Medisize, a Molex company, to scale manufacturing of its Credence Companion and Dual Chamber Reconstitution Systems. The partnership will use Phillips-Medisize's Letterkenny, Ireland and Poland facilities, with potential expansion into autoinjectors and connectivity solutions.Business Wire BlogCredence MedSystems Announces Strategic Collaboration With Phillips-MedisizeCredence MedSystems announced a strategic collaboration with Phillips-Medisize, a Molex company, to scale manufacturing of its Credence Companion and Dual Chamber Reconstitution Systems at Ireland and Poland facilities. The partnership aims to move from clinical to large-scale production with high-volume automation, with potential expansion into autoinjectors and connectivity solutions.BioSpaceCredence MedSystems Secures $39.9 Million Financing to Enable Scaling of Innovative Drug Delivery and Connected Health SystemsCredence MedSystems closed a $39.9 million funding round with strategic investors including Novartis and Molex. The funds will scale production of its Companion and Dual Chamber systems and develop connected health products. The company aims to meet pent-up market demand and support GMP production for clinical use.FinSMEsCredence MedSystems Raises $39.9M in FundingCredence MedSystems, a Menlo Park, California drug delivery systems provider, raised $39.9 million in a round led by Novartis Pharma AG and Molex Ventures LLC. The funds will support scaling production of the Credence Companion and Dual Chamber Reconstitution Systems and developing other platform devices, including its Credence Connect connected syringe portfolio.SecSEC FORM DCredence MedSystems, Inc. filed a Form D with the SEC to report an exempt offering of securities under Rule 506(b), seeking to raise up to $32 million in equity. The company has sold approximately $24.9 million of the total offering amount to 113 investors as of the filing date.Business Wire BlogSCHOTT AG and Credence MedSystems Form a Strategic Collaboration Agreement to Make Syringe Injections Safer for the Benefit of Patients WorldwideSCHOTT AG and Credence MedSystems announced a strategic collaboration to integrate Credence Companion safety technology with SCHOTT's pre-fillable syringe systems. The partnership aims to provide pharmaceutical manufacturers with integrated needle safety systems, including the first such system with a polymer pre-fillable syringe. Implementation timelines and product offerings are being defined.Business Wire BlogCredence MedSystems Receives Award for Best Innovation in Drug Delivery DevicesCredence MedSystems won the Pharmapack Award for Best Innovation in Drug Delivery Devices for its Connect Auto-Sensing Injection System at the Pharmapack conference in Paris. The system provides real-time injection data monitoring and feedback via a reusable finger grip. Credence previously won the same award in 2015 for its Companion Safety Syringe System.Healthcare Packaging2020 Pharmapack Award Winners AnnouncedPharmapack Europe announced eight 2020 award winners across Exhibitor Innovations and Health Products categories. Credence MedSystems and NEMERA won Best Innovation in Drug Delivery Device, while Huhtamaki and PACKSYS won Primary Packaging. Abbott Healthcare and Boehringer Ingelheim won Patient-centric Design and Eco-design, respectively.BenzingaCredence MedSystems Awarded Grant to Develop Its Dual Chamber Drug Delivery Device for the Global HealthCredence MedSystems received a grant from the Bill & Melinda Gates Foundation to develop its Dual Chamber Reconstitution Syringe for use in developing nations. The device aims to reduce human error and needlestick exposure during drug reconstitution. Credence plans to collaborate with Lyophilization Technology, Inc. and may seek a follow-up grant after addressing technical risks.